nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—Etoposide—sarcoma	0.471	1	CrCtD
Podofilox—Teniposide—Etoposide—sarcoma	0.269	1	CrCrCtD
Podofilox—TUBA4A—Vincristine—sarcoma	0.101	0.426	CbGbCtD
Podofilox—TUBB—Vincristine—sarcoma	0.0385	0.163	CbGbCtD
Podofilox—TOP2A—Mitoxantrone—sarcoma	0.0298	0.126	CbGbCtD
Podofilox—TOP2A—Epirubicin—sarcoma	0.0241	0.102	CbGbCtD
Podofilox—TOP2A—Etoposide—sarcoma	0.0188	0.0792	CbGbCtD
Podofilox—TOP2A—Doxorubicin—sarcoma	0.0128	0.0541	CbGbCtD
Podofilox—CYP3A4—Thiotepa—sarcoma	0.00555	0.0234	CbGbCtD
Podofilox—CYP3A4—Mitoxantrone—sarcoma	0.00239	0.0101	CbGbCtD
Podofilox—CYP3A4—Vincristine—sarcoma	0.00164	0.00693	CbGbCtD
Podofilox—CYP3A4—Etoposide—sarcoma	0.00151	0.00635	CbGbCtD
Podofilox—CYP3A4—Doxorubicin—sarcoma	0.00103	0.00433	CbGbCtD
Podofilox—TOP2A—Gastric Cancer Network 1—C21orf33—sarcoma	0.000736	0.177	CbGpPWpGaD
Podofilox—TUBA4A—mammary gland—sarcoma	0.000724	0.0627	CbGeAlD
Podofilox—TUBA4A—myometrium—sarcoma	0.000513	0.0445	CbGeAlD
Podofilox—TUBA4A—seminal vesicle—sarcoma	0.000464	0.0402	CbGeAlD
Podofilox—TUBA4A—hematopoietic system—sarcoma	0.000441	0.0382	CbGeAlD
Podofilox—TUBA4A—connective tissue—sarcoma	0.000425	0.0368	CbGeAlD
Podofilox—TUBA4A—smooth muscle tissue—sarcoma	0.000388	0.0336	CbGeAlD
Podofilox—TUBA4A—skin of body—sarcoma	0.000383	0.0332	CbGeAlD
Podofilox—TOP2A—myometrium—sarcoma	0.00038	0.0329	CbGeAlD
Podofilox—TUBB—myometrium—sarcoma	0.000376	0.0326	CbGeAlD
Podofilox—TUBB—seminal vesicle—sarcoma	0.00034	0.0295	CbGeAlD
Podofilox—TUBA4A—cardiac atrium—sarcoma	0.000335	0.029	CbGeAlD
Podofilox—TUBA4A—uterus—sarcoma	0.000333	0.0288	CbGeAlD
Podofilox—TUBA4A—lymphoid tissue—sarcoma	0.00031	0.0269	CbGeAlD
Podofilox—TUBA4A—tendon—sarcoma	0.000292	0.0253	CbGeAlD
Podofilox—TUBB—smooth muscle tissue—sarcoma	0.000285	0.0247	CbGeAlD
Podofilox—TUBA4A—bone marrow—sarcoma	0.000283	0.0245	CbGeAlD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000274	0.066	CbGpPWpGaD
Podofilox—TOP2A—Vindesine—Vincristine—sarcoma	0.000247	0.218	CbGdCrCtD
Podofilox—TOP2A—uterus—sarcoma	0.000246	0.0213	CbGeAlD
Podofilox—TUBB—cardiac atrium—sarcoma	0.000245	0.0213	CbGeAlD
Podofilox—TUBB—uterus—sarcoma	0.000244	0.0211	CbGeAlD
Podofilox—TUBA4A—testis—sarcoma	0.000242	0.0209	CbGeAlD
Podofilox—TUBB—Pathogenic Escherichia coli infection—EZR—sarcoma	0.000233	0.0561	CbGpPWpGaD
Podofilox—TUBA4A—liver—sarcoma	0.000228	0.0198	CbGeAlD
Podofilox—TOP2A—tendon—sarcoma	0.000216	0.0187	CbGeAlD
Podofilox—TUBB—tendon—sarcoma	0.000214	0.0185	CbGeAlD
Podofilox—TOP2A—bone marrow—sarcoma	0.000209	0.0181	CbGeAlD
Podofilox—TUBB—bone marrow—sarcoma	0.000207	0.0179	CbGeAlD
Podofilox—CYP2C19—hematopoietic system—sarcoma	0.000192	0.0166	CbGeAlD
Podofilox—Skin discolouration—Thiotepa—sarcoma	0.000185	0.0299	CcSEcCtD
Podofilox—TOP2A—testis—sarcoma	0.000179	0.0155	CbGeAlD
Podofilox—TUBB—testis—sarcoma	0.000177	0.0153	CbGeAlD
Podofilox—Ulcer—Dactinomycin—sarcoma	0.000175	0.0284	CcSEcCtD
Podofilox—TUBA4A—lymph node—sarcoma	0.000175	0.0152	CbGeAlD
Podofilox—NR3C1—myometrium—sarcoma	0.000174	0.0151	CbGeAlD
Podofilox—NR3C1—embryo—sarcoma	0.000168	0.0145	CbGeAlD
Podofilox—TUBB—liver—sarcoma	0.000167	0.0145	CbGeAlD
Podofilox—Skin exfoliation—Thiotepa—sarcoma	0.00016	0.0258	CcSEcCtD
Podofilox—NR3C1—seminal vesicle—sarcoma	0.000158	0.0136	CbGeAlD
Podofilox—TOP2A—Vinorelbine—Vincristine—sarcoma	0.000156	0.137	CbGdCrCtD
Podofilox—TOP2A—Teniposide—Etoposide—sarcoma	0.000156	0.137	CbGdCrCtD
Podofilox—Ulcer—Mitoxantrone—sarcoma	0.000153	0.0247	CcSEcCtD
Podofilox—NR3C1—hematopoietic system—sarcoma	0.00015	0.013	CbGeAlD
Podofilox—Tingling sensation—Etoposide—sarcoma	0.000149	0.0241	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—VEGFC—sarcoma	0.000149	0.0359	CbGpPWpGaD
Podofilox—NR3C1—connective tissue—sarcoma	0.000144	0.0125	CbGeAlD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000142	0.0342	CbGpPWpGaD
Podofilox—Skin discolouration—Etoposide—sarcoma	0.000133	0.0215	CcSEcCtD
Podofilox—NR3C1—smooth muscle tissue—sarcoma	0.000132	0.0114	CbGeAlD
Podofilox—NR3C1—skin of body—sarcoma	0.00013	0.0113	CbGeAlD
Podofilox—TOP2A—lymph node—sarcoma	0.00013	0.0112	CbGeAlD
Podofilox—TUBB—lymph node—sarcoma	0.000128	0.0111	CbGeAlD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—ATF1—sarcoma	0.000128	0.0308	CbGpPWpGaD
Podofilox—Ulcer—Etoposide—sarcoma	0.000127	0.0205	CcSEcCtD
Podofilox—Inflammation—Etoposide—sarcoma	0.000124	0.02	CcSEcCtD
Podofilox—Swelling—Mitoxantrone—sarcoma	0.000119	0.0192	CcSEcCtD
Podofilox—Skin exfoliation—Etoposide—sarcoma	0.000115	0.0185	CcSEcCtD
Podofilox—NR3C1—cardiac atrium—sarcoma	0.000114	0.00985	CbGeAlD
Podofilox—CYP3A4—hematopoietic system—sarcoma	0.000113	0.00981	CbGeAlD
Podofilox—NR3C1—uterus—sarcoma	0.000113	0.0098	CbGeAlD
Podofilox—TOP2A—Vinblastine—Vincristine—sarcoma	0.000107	0.0944	CbGdCrCtD
Podofilox—NR3C1—lymphoid tissue—sarcoma	0.000105	0.00913	CbGeAlD
Podofilox—Redness—Epirubicin—sarcoma	9.97e-05	0.0161	CcSEcCtD
Podofilox—CYP2C19—liver—sarcoma	9.92e-05	0.0086	CbGeAlD
Podofilox—NR3C1—tendon—sarcoma	9.91e-05	0.00858	CbGeAlD
Podofilox—Swelling—Etoposide—sarcoma	9.88e-05	0.016	CcSEcCtD
Podofilox—NR3C1—bone marrow—sarcoma	9.6e-05	0.00831	CbGeAlD
Podofilox—Blister—Epirubicin—sarcoma	9.34e-05	0.0151	CcSEcCtD
Podofilox—Redness—Doxorubicin—sarcoma	9.23e-05	0.0149	CcSEcCtD
Podofilox—Haematuria—Thiotepa—sarcoma	8.92e-05	0.0144	CcSEcCtD
Podofilox—Skin ulcer—Epirubicin—sarcoma	8.65e-05	0.014	CcSEcCtD
Podofilox—Blister—Doxorubicin—sarcoma	8.64e-05	0.014	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—FOXO1—sarcoma	8.52e-05	0.0205	CbGpPWpGaD
Podofilox—Haemoglobin—Thiotepa—sarcoma	8.44e-05	0.0136	CcSEcCtD
Podofilox—Haemorrhage—Thiotepa—sarcoma	8.4e-05	0.0136	CcSEcCtD
Podofilox—Stinging—Epirubicin—sarcoma	8.31e-05	0.0134	CcSEcCtD
Podofilox—NR3C1—testis—sarcoma	8.21e-05	0.00711	CbGeAlD
Podofilox—TOP2A—Doxorubicin—Epirubicin—sarcoma	8.13e-05	0.0716	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Epirubicin—sarcoma	8.13e-05	0.0716	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Epirubicin—sarcoma	8.13e-05	0.0716	CbGdCrCtD
Podofilox—Skin ulcer—Doxorubicin—sarcoma	8e-05	0.0129	CcSEcCtD
Podofilox—NR3C1—liver—sarcoma	7.76e-05	0.00672	CbGeAlD
Podofilox—Haematuria—Mitoxantrone—sarcoma	7.7e-05	0.0124	CcSEcCtD
Podofilox—Stinging—Doxorubicin—sarcoma	7.69e-05	0.0124	CcSEcCtD
Podofilox—Immune system disorder—Thiotepa—sarcoma	7.58e-05	0.0123	CcSEcCtD
Podofilox—TOP2A—Epirubicin—Doxorubicin—sarcoma	7.53e-05	0.0662	CbGdCrCtD
Podofilox—TOP2A—Idarubicin—Doxorubicin—sarcoma	7.53e-05	0.0662	CbGdCrCtD
Podofilox—TOP2A—Daunorubicin—Doxorubicin—sarcoma	7.53e-05	0.0662	CbGdCrCtD
Podofilox—Skin discolouration—Epirubicin—sarcoma	7.45e-05	0.012	CcSEcCtD
Podofilox—Erythema—Thiotepa—sarcoma	7.31e-05	0.0118	CcSEcCtD
Podofilox—Haemoglobin—Mitoxantrone—sarcoma	7.29e-05	0.0118	CcSEcCtD
Podofilox—Erythema—Dactinomycin—sarcoma	7.25e-05	0.0117	CcSEcCtD
Podofilox—Haemorrhage—Mitoxantrone—sarcoma	7.25e-05	0.0117	CcSEcCtD
Podofilox—Ulcer—Epirubicin—sarcoma	7.12e-05	0.0115	CcSEcCtD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—CREB1—sarcoma	6.95e-05	0.0167	CbGpPWpGaD
Podofilox—Inflammation—Epirubicin—sarcoma	6.94e-05	0.0112	CcSEcCtD
Podofilox—Skin discolouration—Doxorubicin—sarcoma	6.9e-05	0.0111	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFC—sarcoma	6.62e-05	0.0159	CbGpPWpGaD
Podofilox—Ulcer—Doxorubicin—sarcoma	6.59e-05	0.0106	CcSEcCtD
Podofilox—Skin exfoliation—Epirubicin—sarcoma	6.43e-05	0.0104	CcSEcCtD
Podofilox—Inflammation—Doxorubicin—sarcoma	6.42e-05	0.0104	CcSEcCtD
Podofilox—Erythema—Mitoxantrone—sarcoma	6.31e-05	0.0102	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—CREB1—sarcoma	6.18e-05	0.0149	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	6.18e-05	0.00999	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	5.98e-05	0.0144	CbGpPWpGaD
Podofilox—NR3C1—lymph node—sarcoma	5.95e-05	0.00515	CbGeAlD
Podofilox—Skin exfoliation—Doxorubicin—sarcoma	5.95e-05	0.00961	CcSEcCtD
Podofilox—Oedema—Dactinomycin—sarcoma	5.92e-05	0.00957	CcSEcCtD
Podofilox—CYP3A4—liver—sarcoma	5.87e-05	0.00508	CbGeAlD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	5.81e-05	0.014	CbGpPWpGaD
Podofilox—Skin disorder—Thiotepa—sarcoma	5.79e-05	0.00936	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—CTNNB1—sarcoma	5.47e-05	0.0131	CbGpPWpGaD
Podofilox—Immune system disorder—Etoposide—sarcoma	5.45e-05	0.0088	CcSEcCtD
Podofilox—Paraesthesia—Thiotepa—sarcoma	5.36e-05	0.00866	CcSEcCtD
Podofilox—Oedema—Vincristine—sarcoma	5.29e-05	0.00855	CcSEcCtD
Podofilox—Oedema—Mitoxantrone—sarcoma	5.15e-05	0.00832	CcSEcCtD
Podofilox—Dermatitis bullous—Epirubicin—sarcoma	5.11e-05	0.00826	CcSEcCtD
Podofilox—Pain—Thiotepa—sarcoma	5.1e-05	0.00824	CcSEcCtD
Podofilox—Pain—Dactinomycin—sarcoma	5.06e-05	0.00818	CcSEcCtD
Podofilox—Skin disorder—Mitoxantrone—sarcoma	5e-05	0.00809	CcSEcCtD
Podofilox—TUBB—Pathogenic Escherichia coli infection—CTNNB1—sarcoma	4.94e-05	0.0119	CbGpPWpGaD
Podofilox—Insomnia—Vincristine—sarcoma	4.78e-05	0.00773	CcSEcCtD
Podofilox—Paraesthesia—Vincristine—sarcoma	4.75e-05	0.00768	CcSEcCtD
Podofilox—Dermatitis bullous—Doxorubicin—sarcoma	4.73e-05	0.00765	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—TEK—sarcoma	4.65e-05	0.0112	CbGpPWpGaD
Podofilox—Paraesthesia—Mitoxantrone—sarcoma	4.63e-05	0.00747	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	4.57e-05	0.011	CbGpPWpGaD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—sarcoma	4.54e-05	0.0109	CbGpPWpGaD
Podofilox—Pain—Vincristine—sarcoma	4.52e-05	0.00731	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—STAG1—sarcoma	4.49e-05	0.0108	CbGpPWpGaD
Podofilox—Dry skin—Epirubicin—sarcoma	4.48e-05	0.00724	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	4.44e-05	0.00717	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—sarcoma	4.43e-05	0.0106	CbGpPWpGaD
Podofilox—Pain—Mitoxantrone—sarcoma	4.41e-05	0.00712	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—EGFR—sarcoma	4.33e-05	0.0104	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ANGPT2—sarcoma	4.25e-05	0.0102	CbGpPWpGaD
Podofilox—Pruritus—Thiotepa—sarcoma	4.22e-05	0.00682	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—FOXO1—sarcoma	4.22e-05	0.0101	CbGpPWpGaD
Podofilox—Skin disorder—Etoposide—sarcoma	4.16e-05	0.00673	CcSEcCtD
Podofilox—Dry skin—Doxorubicin—sarcoma	4.14e-05	0.0067	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle—STAG1—sarcoma	4.01e-05	0.00965	CbGpPWpGaD
Podofilox—Dizziness—Thiotepa—sarcoma	3.94e-05	0.00637	CcSEcCtD
Podofilox—Paraesthesia—Etoposide—sarcoma	3.85e-05	0.00622	CcSEcCtD
Podofilox—TUBB—Cell Cycle, Mitotic—STAG1—sarcoma	3.82e-05	0.00917	CbGpPWpGaD
Podofilox—Vomiting—Thiotepa—sarcoma	3.79e-05	0.00613	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—VEGFA—sarcoma	3.79e-05	0.00912	CbGpPWpGaD
Podofilox—Vomiting—Dactinomycin—sarcoma	3.76e-05	0.00608	CcSEcCtD
Podofilox—Rash—Thiotepa—sarcoma	3.76e-05	0.00608	CcSEcCtD
Podofilox—CYP2C19—Melatonin metabolism and effects—FOXO1—sarcoma	3.76e-05	0.00904	CbGpPWpGaD
Podofilox—Dermatitis—Thiotepa—sarcoma	3.76e-05	0.00607	CcSEcCtD
Podofilox—Headache—Thiotepa—sarcoma	3.74e-05	0.00604	CcSEcCtD
Podofilox—Rash—Dactinomycin—sarcoma	3.73e-05	0.00603	CcSEcCtD
Podofilox—Pain—Etoposide—sarcoma	3.66e-05	0.00592	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—TP53—sarcoma	3.64e-05	0.00874	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	3.61e-05	0.00868	CbGpPWpGaD
Podofilox—Haematuria—Epirubicin—sarcoma	3.59e-05	0.0058	CcSEcCtD
Podofilox—NR3C1—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	3.55e-05	0.00853	CbGpPWpGaD
Podofilox—Dizziness—Vincristine—sarcoma	3.5e-05	0.00565	CcSEcCtD
Podofilox—CYP2C19—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.48e-05	0.00835	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—NPM1—sarcoma	3.44e-05	0.00828	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFC—sarcoma	3.41e-05	0.0082	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—STAG1—sarcoma	3.41e-05	0.0082	CbGpPWpGaD
Podofilox—Haemoglobin—Epirubicin—sarcoma	3.4e-05	0.00549	CcSEcCtD
Podofilox—Haemorrhage—Epirubicin—sarcoma	3.38e-05	0.00546	CcSEcCtD
Podofilox—Vomiting—Vincristine—sarcoma	3.36e-05	0.00543	CcSEcCtD
Podofilox—Rash—Vincristine—sarcoma	3.34e-05	0.00539	CcSEcCtD
Podofilox—Dermatitis—Vincristine—sarcoma	3.33e-05	0.00538	CcSEcCtD
Podofilox—Haematuria—Doxorubicin—sarcoma	3.32e-05	0.00537	CcSEcCtD
Podofilox—Headache—Vincristine—sarcoma	3.31e-05	0.00535	CcSEcCtD
Podofilox—Vomiting—Mitoxantrone—sarcoma	3.28e-05	0.00529	CcSEcCtD
Podofilox—Rash—Mitoxantrone—sarcoma	3.25e-05	0.00525	CcSEcCtD
Podofilox—Dermatitis—Mitoxantrone—sarcoma	3.25e-05	0.00524	CcSEcCtD
Podofilox—Headache—Mitoxantrone—sarcoma	3.23e-05	0.00521	CcSEcCtD
Podofilox—Haemoglobin—Doxorubicin—sarcoma	3.14e-05	0.00508	CcSEcCtD
Podofilox—Haemorrhage—Doxorubicin—sarcoma	3.13e-05	0.00505	CcSEcCtD
Podofilox—Immune system disorder—Epirubicin—sarcoma	3.05e-05	0.00493	CcSEcCtD
Podofilox—Pruritus—Etoposide—sarcoma	3.03e-05	0.0049	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	3e-05	0.00722	CbGpPWpGaD
Podofilox—NR3C1—Circadian Clock—CREB1—sarcoma	2.97e-05	0.00714	CbGpPWpGaD
Podofilox—Erythema—Epirubicin—sarcoma	2.94e-05	0.00476	CcSEcCtD
Podofilox—TUBB—Cell Cycle—NPM1—sarcoma	2.93e-05	0.00704	CbGpPWpGaD
Podofilox—Dizziness—Etoposide—sarcoma	2.83e-05	0.00458	CcSEcCtD
Podofilox—Immune system disorder—Doxorubicin—sarcoma	2.83e-05	0.00457	CcSEcCtD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	2.78e-05	0.00668	CbGpPWpGaD
Podofilox—Vomiting—Etoposide—sarcoma	2.72e-05	0.0044	CcSEcCtD
Podofilox—Erythema—Doxorubicin—sarcoma	2.72e-05	0.0044	CcSEcCtD
Podofilox—Rash—Etoposide—sarcoma	2.7e-05	0.00437	CcSEcCtD
Podofilox—Dermatitis—Etoposide—sarcoma	2.7e-05	0.00436	CcSEcCtD
Podofilox—Headache—Etoposide—sarcoma	2.68e-05	0.00434	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—PLCG1—sarcoma	2.68e-05	0.00645	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—STAG1—sarcoma	2.67e-05	0.00642	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—MDM2—sarcoma	2.53e-05	0.00608	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	2.49e-05	0.00402	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—CREB1—sarcoma	2.45e-05	0.00588	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.42e-05	0.00583	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	2.42e-05	0.00581	CbGpPWpGaD
Podofilox—Oedema—Epirubicin—sarcoma	2.4e-05	0.00388	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—STAG1—sarcoma	2.39e-05	0.00574	CbGpPWpGaD
Podofilox—Skin disorder—Epirubicin—sarcoma	2.33e-05	0.00377	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	2.3e-05	0.00372	CcSEcCtD
Podofilox—Oedema—Doxorubicin—sarcoma	2.22e-05	0.00359	CcSEcCtD
Podofilox—NR3C1—Regulation of Androgen receptor activity—JUN—sarcoma	2.2e-05	0.00529	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	2.18e-05	0.00524	CbGpPWpGaD
Podofilox—Insomnia—Epirubicin—sarcoma	2.17e-05	0.00351	CcSEcCtD
Podofilox—Skin disorder—Doxorubicin—sarcoma	2.16e-05	0.00349	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—CREB1—sarcoma	2.16e-05	0.00518	CbGpPWpGaD
Podofilox—Paraesthesia—Epirubicin—sarcoma	2.16e-05	0.00349	CcSEcCtD
Podofilox—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.09e-05	0.00502	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—FOXO1—sarcoma	2.06e-05	0.00494	CbGpPWpGaD
Podofilox—Pain—Epirubicin—sarcoma	2.05e-05	0.00332	CcSEcCtD
Podofilox—TOP2A—Cell Cycle—NPM1—sarcoma	2.05e-05	0.00492	CbGpPWpGaD
Podofilox—Insomnia—Doxorubicin—sarcoma	2.01e-05	0.00325	CcSEcCtD
Podofilox—Paraesthesia—Doxorubicin—sarcoma	2e-05	0.00322	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IL2—sarcoma	1.98e-05	0.00476	CbGpPWpGaD
Podofilox—NR3C1—Regulation of Androgen receptor activity—SRC—sarcoma	1.97e-05	0.00474	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—sarcoma	1.94e-05	0.00466	CbGpPWpGaD
Podofilox—Pain—Doxorubicin—sarcoma	1.9e-05	0.00307	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—IL2—sarcoma	1.81e-05	0.00435	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.79e-05	0.0043	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—CTNNB1—sarcoma	1.79e-05	0.0043	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—MDM2—sarcoma	1.78e-05	0.00429	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CCND1—sarcoma	1.76e-05	0.00424	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—JUN—sarcoma	1.76e-05	0.00423	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—CTNNB1—sarcoma	1.75e-05	0.0042	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—SRC—sarcoma	1.73e-05	0.00415	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—CREB1—sarcoma	1.72e-05	0.00413	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—CCND1—sarcoma	1.7e-05	0.00409	CbGpPWpGaD
Podofilox—Pruritus—Epirubicin—sarcoma	1.7e-05	0.00275	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.68e-05	0.00404	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL2—sarcoma	1.59e-05	0.00383	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—TP53—sarcoma	1.59e-05	0.00383	CbGpPWpGaD
Podofilox—Dizziness—Epirubicin—sarcoma	1.59e-05	0.00257	CcSEcCtD
Podofilox—Pruritus—Doxorubicin—sarcoma	1.57e-05	0.00254	CcSEcCtD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	1.57e-05	0.00377	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—JUN—sarcoma	1.55e-05	0.00373	CbGpPWpGaD
Podofilox—Vomiting—Epirubicin—sarcoma	1.53e-05	0.00247	CcSEcCtD
Podofilox—Rash—Epirubicin—sarcoma	1.51e-05	0.00245	CcSEcCtD
Podofilox—Dermatitis—Epirubicin—sarcoma	1.51e-05	0.00244	CcSEcCtD
Podofilox—Headache—Epirubicin—sarcoma	1.5e-05	0.00243	CcSEcCtD
Podofilox—NR3C1—Adipogenesis—CREB1—sarcoma	1.49e-05	0.00359	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.48e-05	0.00356	CbGpPWpGaD
Podofilox—Dizziness—Doxorubicin—sarcoma	1.47e-05	0.00237	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—sarcoma	1.42e-05	0.0034	CbGpPWpGaD
Podofilox—Vomiting—Doxorubicin—sarcoma	1.41e-05	0.00228	CcSEcCtD
Podofilox—Rash—Doxorubicin—sarcoma	1.4e-05	0.00226	CcSEcCtD
Podofilox—Dermatitis—Doxorubicin—sarcoma	1.4e-05	0.00226	CcSEcCtD
Podofilox—Headache—Doxorubicin—sarcoma	1.39e-05	0.00225	CcSEcCtD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—sarcoma	1.37e-05	0.00328	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.29e-05	0.0031	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CREB1—sarcoma	1.29e-05	0.0031	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.29e-05	0.00309	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.28e-05	0.00307	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	1.26e-05	0.00303	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—JUN—sarcoma	1.24e-05	0.00297	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—FUS—sarcoma	1.17e-05	0.0028	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TP53—sarcoma	1.16e-05	0.00279	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.15e-05	0.00277	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.12e-05	0.0027	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MDM2—sarcoma	1.08e-05	0.00259	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—CTNNB1—sarcoma	1.06e-05	0.00256	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—CCND1—sarcoma	1.05e-05	0.00252	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.03e-05	0.00249	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—TP53—sarcoma	1.02e-05	0.00246	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IL2—sarcoma	1.02e-05	0.00245	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.01e-05	0.00243	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—MMP2—sarcoma	1.01e-05	0.00243	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	9.56e-06	0.0023	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—CCND1—sarcoma	9.39e-06	0.00226	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	9.38e-06	0.00225	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—JUN—sarcoma	9.27e-06	0.00223	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—CTNNB1—sarcoma	9.2e-06	0.00221	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MDM2—sarcoma	9.16e-06	0.0022	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—CCND1—sarcoma	8.93e-06	0.00215	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—SRC—sarcoma	8.9e-06	0.00214	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—VEGFA—sarcoma	8.67e-06	0.00208	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—NRAS—sarcoma	8.56e-06	0.00206	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	8.49e-06	0.00204	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—sarcoma	8.42e-06	0.00202	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—TP53—sarcoma	8.15e-06	0.00196	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—VEGFA—sarcoma	8.1e-06	0.00195	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—CCND1—sarcoma	7.98e-06	0.00192	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CTNNB1—sarcoma	7.75e-06	0.00186	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—sarcoma	7.53e-06	0.00181	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—KRAS—sarcoma	7.37e-06	0.00177	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—sarcoma	7.16e-06	0.00172	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TP53—sarcoma	6.55e-06	0.00157	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MDM2—sarcoma	6.41e-06	0.00154	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—sarcoma	6.4e-06	0.00154	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—HRAS—sarcoma	6.27e-06	0.00151	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	6.24e-06	0.0015	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—TP53—sarcoma	6.18e-06	0.00149	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—CCND1—sarcoma	5.58e-06	0.00134	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—TP53—sarcoma	5.26e-06	0.00126	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	5.01e-06	0.0012	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—sarcoma	4.48e-06	0.00108	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—TP53—sarcoma	3.68e-06	0.000884	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—sarcoma	3.15e-06	0.000757	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO2—sarcoma	2.57e-06	0.000618	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—HBA1—sarcoma	2.55e-06	0.000614	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PLCG1—sarcoma	2.18e-06	0.000524	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO2—sarcoma	1.55e-06	0.000372	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—HBA1—sarcoma	1.54e-06	0.000369	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—sarcoma	1.52e-06	0.000364	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PLCG1—sarcoma	1.31e-06	0.000315	CbGpPWpGaD
